{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:37:29Z","timestamp":1791405449627,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.wneu.2022.10.063","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T12:32:46Z","timestamp":1666269166000},"page":"e37-e44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adjuvant Chemoradiation Therapy Versus Chemotherapy Alone for Resected Oligodendroglioma: A Surveillance, Epidemiology and End Results (SEER) Analysis"],"prefix":"10.1016","volume":"170","author":[{"given":"Kepeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2022.10.063_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/nan.12432","article-title":"WHO 2016 Classification of gliomas","volume":"44","author":"Wesseling","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.wneu.2022.10.063_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.seminoncol.2014.06.009","article-title":"Oligodendroglial tumors","volume":"41","author":"Jaeckle","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib3","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"NEngl J Med"},{"key":"10.1016\/j.wneu.2022.10.063_bib4","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl_5","key":"10.1016\/j.wneu.2022.10.063_bib5","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib6","doi-asserted-by":"crossref","first-page":"851803","DOI":"10.3389\/fonc.2022.851803","article-title":"Early surgery prolongs professional activity in IDH mutant low-grade glioma patients: a policy change analysis","volume":"12","author":"Robe","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00115-010-2956-1","article-title":"[Anaplastic glioma. Neuropathology, molecular diagnostics and current study concepts]","volume":"81","author":"Wick","year":"2010","journal-title":"Nervenarzt"},{"key":"10.1016\/j.wneu.2022.10.063_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2022.10.063_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/10717544.2017.1344334","article-title":"Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma","volume":"24","author":"Zhang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.wneu.2022.10.063_bib10","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","article-title":"Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402","volume":"31","author":"Cairncross","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00401-014-1370-3","article-title":"ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an \u201cintegrated\u201d diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma","volume":"129","author":"Reuss","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2022.10.063_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"van den Bent","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib14","doi-asserted-by":"crossref","first-page":"8888677","DOI":"10.1155\/2020\/8888677","article-title":"Postoperative nomogram for predicting cancer-specific and overall survival among patients with medullary thyroid cancer","volume":"2020","author":"Chen","year":"2020","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.wneu.2022.10.063_bib15","first-page":"948","article-title":"Low-grade gliomas in adults","volume":"115","author":"Sanai","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2022.10.063_bib16","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2018.78.1492","article-title":"Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors","volume":"36","author":"Vatner","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/jnci\/90.19.1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas","volume":"90","author":"Cairncross","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2022.10.063_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/neuonc\/noq177","article-title":"First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response","volume":"13","author":"Taal","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1200\/JCO.2013.49.3726","article-title":"Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH","volume":"32","author":"Cairncross","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib20","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-13-1157","article-title":"MGMT-STP27 methylation status as predictive marker for response to PCV in anaplastic oligodendrogliomas and oligoastrocytomas. A report from EORTC study 26951","volume":"19","author":"van den Bent","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2022.10.063_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(16)30313-8","article-title":"Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study","volume":"17","author":"Baumert","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib22","first-page":"1529","article-title":"Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide","volume":"18","author":"Wick","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0360-3016(01)02692-X","article-title":"Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis","volume":"52","author":"Karim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2022.10.063_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2022.10.063_bib25","doi-asserted-by":"crossref","first-page":"pkac010","DOI":"10.1093\/jncics\/pkac010","article-title":"A\u00a0population-based study of treatment and survival in older glioma patients","volume":"6","author":"Reiner","year":"2022","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.wneu.2022.10.063_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2176\/jns-nmc.2021-0313","article-title":"Malignant progression of diffuse low-grade gliomas: a systematic review and meta-analysis on incidence and related factors","volume":"62","author":"Nakasu","year":"2022","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.wneu.2022.10.063_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/cancers12010050","article-title":"Application of an artificial intelligence algorithm to prognostically stratify grade II gliomas","volume":"12","author":"Cesselli","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.wneu.2022.10.063_bib28","first-page":"1","article-title":"Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis","volume":"10","author":"Kavouridis","year":"2019","journal-title":"Neurosurg"},{"key":"10.1016\/j.wneu.2022.10.063_bib29","doi-asserted-by":"crossref","first-page":"769345","DOI":"10.3389\/fneur.2021.769345","article-title":"T2 FLAIR hyperintensity volume is associated with cognitive function and quality of life in clinically stable patients with lower grade gliomas","volume":"12","author":"Luks","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.wneu.2022.10.063_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrneurol.2016.185","article-title":"Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours","volume":"13","author":"Makale","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.wneu.2022.10.063_bib31","first-page":"463","article-title":"Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment","volume":"6","author":"van Kessel","year":"2019","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.wneu.2022.10.063_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-017-2418-8","article-title":"Does early resection of presumed low-grade glioma improve survival? A clinical perspective","volume":"133","author":"Wijnenga","year":"2017","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1468-1331.2010.03151.x","article-title":"Guidelines on management of low-grade gliomas: report of an EFNS-EANO task force","volume":"17","author":"Soffietti","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1016\/j.wneu.2022.10.063_bib34","first-page":"1175","article-title":"Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p","volume":"145","author":"Reifenberger","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.wneu.2022.10.063_bib35","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.ejca.2006.05.021","article-title":"1p\/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment","volume":"42","author":"Kouwenhoven","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.wneu.2022.10.063_bib36","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","article-title":"Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma","volume":"374","author":"Buckner","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2022.10.063_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2012.00073","article-title":"Radiation-induced brain injury: a review","volume":"2","author":"Greene-Schloesser","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2022.10.063_bib38","doi-asserted-by":"crossref","first-page":"102124","DOI":"10.1016\/j.ctrv.2020.102124","article-title":"A\u00a0basic review on systemic treatment options in WHO grade II-III gliomas","volume":"92","author":"Mair","year":"2021","journal-title":"Cancer Treat Rev"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022014802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022014802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:19:34Z","timestamp":1761815974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875022014802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":38,"alternative-id":["S1878875022014802"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2022.10.063","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant Chemoradiation Therapy Versus Chemotherapy Alone for Resected Oligodendroglioma: A Surveillance, Epidemiology and End Results (SEER) Analysis","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2022.10.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}